← Back to Search

Other

Enhanced Memory Care Environment for Dementia

N/A
Recruiting
Led By Ying Ying Chen, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every 2 weeks for up to one year
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new way to care for people with dementia that could potentially improve their quality of life.

Who is the study for?
This trial is for patients living in the Arbor Terrace memory care unit who have been diagnosed with dementia. It's not suitable for hospice patients expected to live less than 30 days.
What is being tested?
The study is testing a redesigned room equipped with technological enhancements aimed at improving the quality of care for individuals with dementia.
What are the potential side effects?
Since this trial involves environmental and technological changes rather than medications, traditional side effects are not applicable. However, there may be adjustments needed as residents adapt to new surroundings.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every 2 weeks for up to one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and every 2 weeks for up to one year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Delirium
Change in falls
Change in function and independence, as measured by the Katz Index of Independence in Activities of Daily living (KATZ)
+4 more
Secondary study objectives
Change in caregiver burden, as measured by the Caregiver Strain Index (CSI)
Other study objectives
Change in emergency room and hospitalizations

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Subjects with dementia will be living in a retro-fitted room with technological enhancements for a 12 month period.
Group II: Standard of Care GroupActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,343 Previous Clinical Trials
3,062,329 Total Patients Enrolled
26 Trials studying Dementia
16,877 Patients Enrolled for Dementia
Ying Ying Chen, MDPrincipal InvestigatorMayo Clinic

Media Library

Retro-fitted room with technological enhancements (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04350060 — N/A
Dementia Research Study Groups: Intervention Group, Standard of Care Group
Dementia Clinical Trial 2023: Retro-fitted room with technological enhancements Highlights & Side Effects. Trial Name: NCT04350060 — N/A
Retro-fitted room with technological enhancements (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04350060 — N/A
~3 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top